CaMello-XR Enables Visualization and Optogenetic Control of G Signals and Receptor Trafficking in GPCR-specific Domains
Overview
Authors
Affiliations
The signal specificity of G protein-coupled receptors (GPCRs) including serotonin receptors (5-HT-R) depends on the trafficking and localization of the GPCR within its subcellular signaling domain. Visualizing traffic-dependent GPCR signals in neurons is difficult, but important to understand the contribution of GPCRs to synaptic plasticity. We engineered CaMello (Ca-melanopsin-local-sensor) and CaMello-5HT for visualization of traffic-dependent Ca signals in 5-HT-R domains. These constructs consist of the light-activated G coupled melanopsin, mCherry and GCaMP6m for visualization of Ca signals and receptor trafficking, and the 5-HT C-terminus for targeting into 5-HT-R domains. We show that the specific localization of the GPCR to its receptor domain drastically alters the dynamics and localization of the intracellular Ca signals in different neuronal populations in vitro and in vivo. The CaMello method may be extended to every GPCR coupling to the G pathway to help unravel new receptor-specific functions in respect to synaptic plasticity and GPCR localization.
Barzan R, Bozkurt B, Nejad M, Suss S, Surdin T, Boke H Nat Commun. 2024; 15(1):8078.
PMID: 39277631 PMC: 11401874. DOI: 10.1038/s41467-024-51861-1.
Ouyang D, Liu Y, Xie W J Pain Res. 2024; 17:2407-2415.
PMID: 39050680 PMC: 11268570. DOI: 10.2147/JPR.S460566.
Synthetic surprise as the foundation of the psychedelic experience.
De Filippo R, Schmitz D Neurosci Biobehav Rev. 2024; 157:105538.
PMID: 38220035 PMC: 10839673. DOI: 10.1016/j.neubiorev.2024.105538.
Zhou F, Tichy A, Imambocus B, Sakharwade S, Rodriguez Jimenez F, Gonzalez Martinez M Nat Commun. 2023; 14(1):8434.
PMID: 38114457 PMC: 10730509. DOI: 10.1038/s41467-023-43970-0.
Optical Approaches for Investigating Neuromodulation and G Protein-Coupled Receptor Signaling.
Marcus D, Bruchas M Pharmacol Rev. 2023; 75(6):1119-1139.
PMID: 37429736 PMC: 10595021. DOI: 10.1124/pharmrev.122.000584.